GlassScriptPhysician profile
Michael J Sebahar
NPI 1558325365
$2,220.54
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,090 · 2020: $54.49 · 2021: $60.59 · 2023: $15.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $869.45 | 2019-2020 | |
| Medtronic USA, INC. | $470.19 | 2019 | |
| Boston Scientific Corporation | $296.44 | 2019-2023 | |
| Nevro Corp. | $96.84 | 2019 | |
| Electronic Waveform Lab, INC. | $94.99 | 2019 | |
| Tersera Therapeutics LLC | $54.50 | 2019 | |
| Pfizer INC. | $46.98 | 2019 | |
| Nuvasive, INC. | $44.65 | 2019 | |
| Scilex Pharmaceuticals INC. | $42.36 | 2019 | |
| Zyla Life Sciences, INC. | $29.49 | 2019 | |
| Masimo Corporation | $19.74 | 2021 | |
| Depuy Synthes Sales INC. | $19.70 | 2019 | |
| Arbor Pharmaceuticals, INC. | $19.68 | 2019 | |
| Assertio Therapeutics, INC. | $19.25 | 2019 | |
| Spr Therapeutics, INC | $19.14 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $18.92 | 2019 | |
| Vertiflex, INC. | $18.64 | 2019 | |
| Fidia Pharma USA INC. | $14.78 | 2019 | |
| Piramal Critical Care | $13.97 | 2019 | |
| Kaleo, INC. | $10.83 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sebahar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.